Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    64,125.14
    +689.54 (+1.09%)
     

  • CMC Crypto 200

    1,334.09
    +21.47 (+1.58%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • Dow

    37,986.40
    +211.02 (+0.56%)
     

  • Nasdaq

    15,282.01
    -319.49 (-2.05%)
     

  • Gold

    2,403.10
    +5.10 (+0.21%)
     

  • Crude Oil

    83.26
    +0.53 (+0.64%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Heron Therapeutics (HRTX) Looks Good: Stock Adds 6.8% in Session

Zacks Equity Research
·1-min read

Heron Therapeutics, Inc. HRTX was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.This continues the recent uptrend for the company—as the stock is now up 23% in the past one-month time frame.

The company's Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for Tailored Brands. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Heron Therapeutics has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Heron Therapeutics, Inc. Price

Heron Therapeutics, Inc. Price
Heron Therapeutics, Inc. Price

Heron Therapeutics, Inc. price | Heron Therapeutics, Inc. Quote

ADVERTISEMENT

Investors interested in the Medical - Drugs industry may consider Catalent, Inc. CTLT which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

 

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Catalent, Inc. (CTLT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research